Nova Biomedical

Advanced Instruments has merged with Nova Biomedical, uniting two innovation-driven organizations to form a larger, global life science tools company operating under the Nova Biomedical name. This strategic combination broadens our expertise in bioprocessing and clinical diagnostics, strengthening our capacity to serve customers and create lasting impact across the life sciences and healthcare industries. Nova Biomedical is a global leader in in vitro diagnostic (IVD) and biotechnology instrumentation, dedicated to advancing patient care and scientific discovery through cutting-edge technology. Our portfolio includes: Clinical Diagnostics: Blood gas, critical care, and glucose analyzers that deliver fast, accurate results to support better clinical decisions. Biotech Solutions: Innovative instruments for real-time cell culture monitoring and process optimization in biomanufacturing. Veterinary Diagnostics: High-performance analyzers tailored for animal health applications. With significant revenue reinvested annually into R&D, we maintain a strong pipeline of breakthrough technologies. As the largest privately held IVD company in the U.S. and one of the fastest-growing globally, we serve customers in over 100 countries. Our culture is built on mutual respect, integrity, and long-term commitment—reflected in the loyalty of our people and the trust of our customers. Learn more: www.novabiomedical.com